A drug which is currently used to treat cancer may assist in the treatment of a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus, reveal scientists.
Japanese scientists used mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed.
Wide Range of Inflammatory Diseases may be Treated by Cancer Drug
A range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may be treated by a drug already available for treating cancer.
Advertisement
If the results prove true in humans, it offers hope that this drugs or others similar to it might be used to treat inflammatory diseases without the side effects of current drugs that affect all T cells equally.
"Unfortunately, there are a lot of people who are suffering from autoimmune and inflammatory disease," said Koichi Yanaba, a scientist from the Department of Dermatology at Nagasaki University Graduate School of Biomedical Sciences who was involved in the research.
![Study Finds Molecule Behind Diverse Human Chronic Inflammatory Diseases]( "Study Finds Molecule Behind Diverse Human Chronic Inflammatory Diseases")
Virginia Tech researchers have uncovered a common connection between the cellular innate immunity network and chronic inflammatory diseases like atherosclerosis, Type 2 Diabetes, and
"We believe that this new-type remedy for autoimmune and inflammatory disease could successfully treat them in the near future," Yanaba added.
To make this discovery, scientists used two groups of mice-the first treated with bortezomib and the second with saline. Researchers induced contact hypersensitivity reaction with oxazolone, a chemical allergen used for immunological experiments and found that bortezomib significantly inhibited the contact hypersensitivity responses.
Results strongly suggest that bortezomib treatment enhanced T cell death by inhibiting NF-kappa B activation, which plays a key role in regulating the immune response to infection.
This in turn led to the suppression of inflammatory responses in immune cells by reducing interferon-gamma production.
The study has been published in the July 2010 print issue of the Journal of Leukocyte Biology.
Source: ANI
Study Finds Molecule Behind Diverse Human Chronic Inflammatory Diseases
Virginia Tech researchers have uncovered a common connection between the cellular innate immunity network and chronic inflammatory diseases like atherosclerosis, Type 2 Diabetes, and
Advertisement
"We believe that this new-type remedy for autoimmune and inflammatory disease could successfully treat them in the near future," Yanaba added.
To make this discovery, scientists used two groups of mice-the first treated with bortezomib and the second with saline. Researchers induced contact hypersensitivity reaction with oxazolone, a chemical allergen used for immunological experiments and found that bortezomib significantly inhibited the contact hypersensitivity responses.
Results strongly suggest that bortezomib treatment enhanced T cell death by inhibiting NF-kappa B activation, which plays a key role in regulating the immune response to infection.
This in turn led to the suppression of inflammatory responses in immune cells by reducing interferon-gamma production.
The study has been published in the July 2010 print issue of the Journal of Leukocyte Biology.
Source: ANI
Drug-delivery System Devised by Indian-origin Researcher may Improve Inflammatory Diseases Treatment
A Georgia Tech researcher of Indian origin has developed biodegradable polymers called polyketals that may improve treatment for acute inflammatory illnesses by delivering therapeutics
Advertisement
 Purple Periwinkles may be Useful to Treat Inflammatory DiseasesVinpocetine, a natural product from the periwinkle plant, can work as an anti-inflammatory agent holding promise for the treatment of chronic obstructive pulmonary disease. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.